m18f1av | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/0m18f1av_hasAnnotation_C0038586>
?:creator	<https://research.tib.eu/covid-19/entity/Faur%2C_Rebeca%3B_Irazoqui%2C_Gustavo%3B_Pavlovsky%2C_Federico%3B_Wikinski%2C_Silvia>
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.drugalcdep.2020.108359>
?:doi	10.1016/j.drugalcdep.2020.108359
?:journal	Drug_Alcohol_Depend
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/ce7dfa67eefdee53314ad590c6997f7f07501d56.json
?:pmc_json_files	document_parses/pmc_json/PMC7568517.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7568517>
?:pmid	<https://research.tib.eu/covid-19/entity/33109459.0>
?:pmid	33109459.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/0m18f1av_HAS_C0038586_COEXISTS_WITH_C5203670>
?:sha_id	<https://research.tib.eu/covid-19/entity/ce7dfa67eefdee53314ad590c6997f7f07501d56>
?:source	Elsevier; Medline; PMC
?:title	EXPANDING ACCESSIBILITY: OUTPATIENT INTENSIVE TREATMENT FOR SUBSTANCE USE DISORDER DURING COVID19 PANDEMIC
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-10-17

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/0m18f1av>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/0m18f1av>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all